Agency News
'Why buy a network that even Dentsu couldn’t fix?': Inside the gamble of Dentsu's international arm sale
The Kerala High Court has granted a stay in the criminal proceedings against Patanjali Ayurved’s promoters, Baba Ramdev and Acharya Balkrishna, and Divya Pharmacy. The time period of the stay, which was granted on April 3, 2025, is of three months.
Justice VG Arun stayed the proceedings pending before the Judicial First Class Magistrate Court II in Palakkad.
The case stems from a complaint filed by Kerala's Drugs Inspector, who accused Divya Pharmacy of violating provisions of The Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954. Specifically, the complaint cites violations of Sections 3, 3(b), and 3(d), which prohibit advertising certain drugs for specific diseases, sexual enhancement claims, and unsubstantiated health benefits.
In this legal proceeding, Divya Pharmacy is named as the first accused, with Acharya Balkrishna and Baba Ramdev listed as the second and third accused, respectively.
This is not the first time Patanjali Ayurved has faced legal scrutiny for its marketing practices. The company came under fire for publishing advertisements that allegedly disparaged modern medicine, particularly Allopathy. The Supreme Court previously issued a contempt notice against Patanjali for continuing to run such ads, but the case was later closed after Ramdev, Balkrishna, and Patanjali offered a public apology.
Today’s B2B marketers wear many hats: strategist, technologist, and storyteller.
Read MoreThe Online Gaming Bill 2025 imposes severe penalties, allows warrantless search and seizure, and empowers a central authority to regulate the digital gaming ecosystem. It is expected to disrupt platforms, payment systems, and advertising in the sector. Here's all you need to know about the bill.